Literature DB >> 27142204

New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors.

Mamadou S Sow1, Jean-François Etard2, Sylvain Baize3, N'Fally Magassouba4, Ousmane Faye5, Philippe Msellati2, Abdoulaye Touré6,7, Ibrahima Savane8, Moumié Barry1, Eric Delaporte2.   

Abstract

Ninety-eight semen specimens were obtained for Ebola virus (EBOV) RNA screening from 68 men in Guinea during the convalescent phase of EBOV infection. Ten samples from 8 men were positive for EBOV up to 9 months after onset of the disease, with decreasing trends in the proportion of positive samples and the level of viral RNA. Safe sex practices should be observed after discharge from treatment centers.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Ebola virus; Guinea; outbreak; semen; survivors; virus persistence

Mesh：

Substances：

Year:  2016        PMID： 27142204     DOI： 10.1093/infdis/jiw078

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  37 in total

1.  Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.

Authors:  John C Kash; Kathie-Anne Walters; Jason Kindrachuk; David Baxter; Kelsey Scherler; Krisztina B Janosko; Rick D Adams; Andrew S Herbert; Rebekah M James; Spencer W Stonier; Matthew J Memoli; John M Dye; Richard T Davey; Daniel S Chertow; Jeffery K Taubenberger
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

2.  Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys.

Authors:  Xiankun Zeng; Candace D Blancett; Keith A Koistinen; Christopher W Schellhase; Jeremy J Bearss; Sheli R Radoshitzky; Shelley P Honnold; Taylor B Chance; Travis K Warren; Jeffrey W Froude; Kathleen A Cashman; John M Dye; Sina Bavari; Gustavo Palacios; Jens H Kuhn; Mei G Sun
Journal:  Nat Microbiol       Date:  2017-07-17       Impact factor: 17.745

3.  Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016.

Authors:  Joel G Breman; David L Heymann; Graham Lloyd; Joseph B McCormick; Malonga Miatudila; Frederick A Murphy; Jean-Jacques Muyembé-Tamfun; Peter Piot; Jean-François Ruppol; Pierre Sureau; Guido van der Groen; Karl M Johnson
Journal:  J Infect Dis       Date:  2016-06-29       Impact factor: 5.226

4.  Serological Investigation of Laboratory-Confirmed and Suspected Ebola Virus Disease Patients During the Late Phase of the Ebola Outbreak in Sierra Leone.

Authors:  Yang Liu; YuLan Sun; Wei Wu; AQian Li; XianDa Yang; Shuo Zhang; Chuan Li; QiuDong Su; ShaoJian Cai; DaPeng Sun; HaiYang Hu; Zhe Zhang; XiuXu Yang; Idrissa Kamara; Sheku Koroma; Gerald Bangura; Alie Tia; Abdul Kamara; Matt Lebby; Brima Kargbo; Jiandong Li; Shiwen Wang; XiaoPing Dong; YueLong Shu; WenBo Xu; George F Gao; GuiZhen Wu; DeXin Li; William J Liu; MiFang Liang
Journal:  Virol Sin       Date:  2018-07-31       Impact factor: 4.327

Review 5.  Persistent RNA virus infections: do PAMPS drive chronic disease?

Authors:  Mary K McCarthy; Thomas E Morrison
Journal:  Curr Opin Virol       Date:  2017-02-17       Impact factor: 7.090

6.  Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.

Authors:  Ahidjo Ayouba; Abdoulaye Touré; Christelle Butel; Alpha Kabinet Keita; Florian Binetruy; Mamadou S Sow; Vincent Foulongne; Eric Delaporte; Martine Peeters
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

7.  Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles.

Authors:  Haoyang Li; Fei Yu; Shuai Xia; Yufeng Yu; Qian Wang; Ming Lv; Yan Wang; Shibo Jiang; Lu Lu
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

8.  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Authors:  Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

9.  Ebola Virus Shedding and Transmission: Review of Current Evidence.

Authors:  Pauline Vetter; William A Fischer; Manuel Schibler; Michael Jacobs; Daniel G Bausch; Laurent Kaiser
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

Review 10.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.